We are proud to announce that CINP 2026 will collaborate with Glasgow Children’s Hospital Charity to support the National Child Psychiatry Unit (Ward 4) at the Royal Hospital for Children in Glasgow. Ward 4 is the only unit of its kind in Scotland, caring for children under 12 from across the country. Many patients stay for months at a time, making safe, supportive, and creative environments essential to their care and wellbeing. During CINP 2026, the Charity will also host a charity shop at the congress venue, where participants can support this important work by purchasing merchandise and souvenirs and learn more about the charity activities. Join us in Glasgow and be part of something meaningful - together, we can support children, families, and clinical teams when it matters most. | Thank you to everyone who joined the joint scientific meeting between CINP and the Institute of Brain Medicine that took place in Hong Kong on January 18, 2026. The meeting brought together colleagues for thoughtful and engaging discussions on the future of psychiatry, including artificial intelligence, digital technologies, and innovation in drug development. The quality of exchange and the collegial atmosphere made the day a real success. We are grateful to our speakers, partners, and all participants for contributing to such a meaningful scientific gathering. We hope this fruitful collaboration will continue in the following years. |
Introducing CINP 2026 Keynote Speakers: Professor Barbara J. Sahakian (UK) Professor Barbara Sahakian is an internationally renowned leader in psychiatric neuroscience, with a distinguished career spanning psychopharmacology, neuropsychology, neuroethics, and public policy. Based at the University of Cambridge, her work has had a lasting impact on how we understand brain health, cognition, and mental health across the lifespan. Her keynote lecture at CINP 2026 in Glasgow will be: Psychiatric Neuroscience: Improving Brain Health, Cognition and Mental Health |
We are excited to announce the preparation of an International Course in Psychopharmacology, designed for residents in psychiatry and neurology, psychiatrists, neurologists, and general practitioners, and everybody who wishes to deepen their understanding of the mechanisms and clinical applications of psychopharmacological treatments. Through this program, CINP seeks to foster global learning, professional development, and the dissemination of evidence-based neuropsychopharmacology. The course will be online, CME-accredited, with sessions held every Thursday for several consecutive weeks. The first edition of the course is planned for the second half of 2026. More information coming soon! |
This year’s CINP Ethics Prize is awarded to Prof. K. Sonu Gaind in recognition of his exceptional leadership at the intersection of clinical psychiatry, psychopharmacology, and public policy. Through decades of academic, clinical, and international service - and particularly through his influential, evidence-based engagement on the ethical dimensions of Medical Assistance in Dying (MAiD) in the context of mental illness - Prof. Gaind has helped shape ethical discourse, informed policy development, and advocated for the protection of vulnerable populations. His work exemplifies the principles of ethical responsibility, public engagement, and global impact that this award seeks to honour. |
We are deeply saddened to announce the passing of Professor Dan Stein, a long-standing CINP Fellow whose contributions to neuropsychopharmacology have left a profound and lasting impact on our field. Professor Stein was widely recognised for his scientific excellence, his leadership, and his unwavering dedication to advancing mental health research both in Africa and globally. We join colleagues around the world in honouring his scientific legacy and remarkable impact on neuropsychopharmacology. The CINP extends its heartfelt condolences to his family, friends, and all who had the privilege of working with him.
|
GLOBAL
|